Dr Reddys Laboratories Share Price Today - Live Blog for September 03, 2025

Dr Reddys Laboratories Ltd's share price has dropped by -0.02%, a development that warrants careful analysis. Presently trading at ₹1,262.40, investors are assessing whether this presents an opportunity or a risk.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.04% in its share price, and it currently trades at ₹1,262.35 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price rallied by 0.17%, reaching the current market price of ₹1,261.65. This surge is indicative of the stock's recent positive performance.

After a -0.20% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,259.50. The stock has a PE ratio of 18.4700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has fallen by -0.07%, a situation worth noting. At present, the stock is trading at ₹1,262.65. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.4700, while the industry PE ratio is 34.3513.

After a -0.07% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,262.65. The stock has a PE ratio of 18.4700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Following a noteworthy 0.08% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,263.50. When it comes to valuation, this stock has a PE ratio of 18.4700, with the industry PE ratio at 34.3513.

Dr Reddys Laboratories Ltd witnessed a -0.01% drop in its share price and is currently trading at ₹1,262.45. With the stock's PE at 18.4700 and the industry PE at 34.3513, investors are weighing their options.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.06%, with its current market value per share resting at ₹1,264.40. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd witnessed a substantial 0.06% increase in its share price and is currently trading at ₹1,264.40. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd share price surged by 0.21%. With its current market price standing at ₹1,264.40 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd's share price rallied by 0.04%, reaching the current market price of ₹1,262.70. This surge is indicative of the stock's recent positive performance.

The stock of Dr Reddys Laboratories Ltd suffered a -0.12% decline, and it currently trades at ₹1,262.15 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd's shares experienced a 0.15% uptick, and they are currently valued at ₹1,263.75, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Demonstrating a commendable 0.15% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,263.75. In terms of valuation, the stock maintains a PE ratio of 18.4700, while the industry PE ratio stands at 34.3513.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.13% upswing, and it's currently trading at ₹1,261.85 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd observed a -0.03% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,261.05. The stock has a PE ratio of 18.4700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.16% in its share price, and it currently trades at ₹1,261.20 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.49%, with its current market value per share resting at ₹1,263.25. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd's share price rallied by 0.41%, reaching the current market price of ₹1,257.10. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd's share price has fallen by -0.07%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,252.00, and market participants are assessing the implications. The stock has a PE ratio of 18.4700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd plunged by -0.18%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,252.85, but investors are assessing whether this is a temporary dip or a long-term trend.

The stock of Dr Reddys Laboratories Ltd is facing a -0.32% decline and is currently trading at ₹1,255.00 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

With a remarkable 0.23% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,259.00. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.4700, while the industry's PE ratio is 34.3513.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.24%, reaching the current market price of ₹1,256.20. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

After a notable 0.17% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,254.00. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.35%, reaching the current market price of ₹1,252.40. This development underscores the stock's growing popularity.